PMID- 9388274 OWN - NLM STAT- MEDLINE DCOM- 19980108 LR - 20210209 IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 272 IP - 49 DP - 1997 Dec 5 TI - Heat shock activates c-Src tyrosine kinases and phosphatidylinositol 3-kinase in NIH3T3 fibroblasts. PG - 31196-202 AB - There is increasing evidence that cellular responses to stress are in part regulated by protein kinases, although specific mechanisms are not well defined. The purpose of these experiments was to investigate potential upstream signaling events activated during heat shock in NIH3T3 fibroblasts. Experiments were designed to ask whether heat shock activates p60 c-Src tyrosine kinase or phosphatidylinositol 3-kinase (PI 3-kinase). Using in vitro protein kinase activity assays, it was demonstrated that heat shock stimulates c-Src and PI 3-kinase activity in a time-dependent manner. Also, there was increased PI 3-kinase activity in anti-phosphotyrosine and anti-c-Src immunoprecipitated immunocomplexes from heated cells. Heat shock activated mitogen-activated protein kinase (MAPK) and p70 S6 kinase (S6K) in these cells. The role of PI 3-kinase in regulating heat shock activation of MAPK and p70 S6K was investigated using wortmannin, a specific pharmacological inhibitor of PI 3-kinase. The results demonstrated that wortmannin inhibited heat shock activation of p70 S6K but only partially inhibited heat activation of MAPK. A dominant negative Raf mutant inhibited activation of MAPK by heat shock but did not inhibit heat shock stimulation of p70 S6K. Genistein, a tyrosine kinase inhibitor, and suramin, a growth factor receptor inhibitor, both inhibited heat shock stimulation of MAPK activity and tyrosine phosphorylation of MAPK. Furthermore, a selective epidermal growth factor receptor (EGFR) inhibitor, tryphostin AG1478, and a dominant negative EGFR mutant also inhibited heat shock activation of MAPK. Heat shock induced EGFR phosphorylation. These results suggest that early upstream signaling events in response to heat stress may involve activation of PI 3-kinase and tyrosine kinases, such as c-Src, and a growth factor receptor, such as EGFR; activation of important downstream pathways, such as MAPK and p70 S6K, occur by divergent signaling mechanisms similar to growth factor stimulation. FAU - Lin, R Z AU - Lin RZ AD - Veterans Affairs Palo Alto Health Care System and Geriatrics Research, Education and Clinical Center, Palo Alto, California 94304, USA. FAU - Hu, Z W AU - Hu ZW FAU - Chin, J H AU - Chin JH FAU - Hoffman, B B AU - Hoffman BB LA - eng GR - HL41315/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Androstadienes) RN - 0 (Enzyme Inhibitors) RN - EC 2.7.1.- (Phosphatidylinositol 3-Kinases) RN - EC 2.7.10.1 (ErbB Receptors) RN - EC 2.7.11.1 (Ribosomal Protein S6 Kinases) RN - EC 2.7.11.17 (Calcium-Calmodulin-Dependent Protein Kinases) RN - XVA4O219QW (Wortmannin) SB - IM MH - 3T3 Cells MH - Androstadienes/administration & dosage/pharmacology MH - Animals MH - Calcium-Calmodulin-Dependent Protein Kinases/antagonists & inhibitors/*metabolism MH - Dose-Response Relationship, Drug MH - Enzyme Activation MH - Enzyme Inhibitors/administration & dosage/pharmacology MH - ErbB Receptors/metabolism MH - Fibroblasts/enzymology MH - *Hot Temperature MH - Mice MH - Phosphatidylinositol 3-Kinases/*metabolism MH - Ribosomal Protein S6 Kinases/antagonists & inhibitors/*metabolism MH - Signal Transduction MH - Wortmannin EDAT- 1998/01/10 00:00 MHDA- 1998/01/10 00:01 CRDT- 1998/01/10 00:00 PHST- 1998/01/10 00:00 [pubmed] PHST- 1998/01/10 00:01 [medline] PHST- 1998/01/10 00:00 [entrez] AID - S0021-9258(19)89667-9 [pii] AID - 10.1074/jbc.272.49.31196 [doi] PST - ppublish SO - J Biol Chem. 1997 Dec 5;272(49):31196-202. doi: 10.1074/jbc.272.49.31196.